CAZZANIGA, GIOVANNI

CAZZANIGA, GIOVANNI  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 274 (tempo di esecuzione: 0.017 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia 01 - Articolo su rivista 2025 Saettini, FrancescoGuerra, FabiolaMauri, MarioChinello, CliziaDenti, VannaFazio, GraziaMalighetti, FedericaPagani, LisaQuadri, ManuelRebellato, StefanoSavino, Angela MariaMagni, FulvioPaglia, GiuseppeCazzaniga, GianniPiazza, RoccoBiondi, Andrea +
Cytogenetically Balanced Reciprocal Translocation Could Hide Molecular Genomic Unbalances: Implications for Foetal Phenotype Correlation 01 - Articolo su rivista 2024 Villa N.Redaelli S.Farina S.Sala E.Crosti F.Cozzolino S.Verderio M.Roversi G.Bentivegna A.Cazzaniga G.Lavitrano M.Conconi D. +
Diverse mechanisms of leukemogenesis associated with PAX5 germline mutation 01 - Articolo su rivista 2024 Bettini L. R.Fazio G.Saitta C.Piazza R.Palamini S.Buracchi C.Rebellato S.Biondi A.Cazzaniga G. +
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis 01 - Articolo su rivista 2024 Crespiatico I.Mastini C.D'Aliberti D.Mauri M.Mercado C. M.Fontana D.Spinelli S.Crippa V.Inzoli E.Manghisi B.Civettini I.Ramazzotti D.Sangiorgio V.Brambilla V.Aroldi A.Barone C.Orsenigo R.Serafini M.Mottadelli F.Cazzaniga G.Pagni F.Azzoni E.Gambacorti Passerini C.Elli E. M.Mologni L.Piazza R. +
Four Additional Doses of PEG-L-Asparaginase during the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study 01 - Articolo su rivista 2024 Valsecchi M. G.Rizzari C.Cazzaniga G.Biondi A. +
Idiopathic erythrocytosis: a germline disease? 01 - Articolo su rivista 2024 Elli, E. M.Mauri, M.D’Aliberti, D.Crespiatico, I.Fontana, D.Redaelli, S.Pelucchi, S.Spinelli, S.Manghisi, B.Cavalca, F.Aroldi, A.Ripamonti, A.Palamini, S.Mottadelli, F.Massimino, L.Ramazzotti, D.Cazzaniga, G.Piperno, A.Gambacorti-Passerini, C.Piazza, R. +
Antibody Deficiency in Patients with Biallelic KARS1 Mutations 01 - Articolo su rivista 2023 Saettini F.Guerra F.Fazio G.Ardissone A.Quadri M.Mauri M.Piazza R.Cazzaniga G.Biondi A. +
BEYOND THE TUMOUR: CHILDHOOD CANCER PREDISPOSING SYNDROMES [Guardare oltre il tumore: le cancer-predisposingsyndrome in età pediatrica] 01 - Articolo su rivista 2023 Bettini L. R.Lauriola R. S.Coliva T.Biondi A.Cazzaniga G. +
Correction to: Antibody Deficiency in Patients with Biallelic KARS1 Mutations (Journal of Clinical Immunology, (2023), 43, 8, (2115-2125), 10.1007/s10875-023-01584-7) 99 - Altro 2023 Saettini F.Guerra F.Fazio G.Ardissone A.Romano R.Quadri M.Gasperini S.Mauri M.Piazza R.Cazzaniga G.Biondi A. +
Dasatinib with intensive chemotherapy in de novo paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (CA180-372/COG AALL1122): a single-arm, multicentre, phase 2 trial 01 - Articolo su rivista 2023 Valsecchi M. G.Cazzaniga G.Biondi A. +
Definition and Prognostic Value of Ph-like and IKZF1plus Status in Children With Down Syndrome and B-cell Precursor Acute Lymphoblastic Leukemia 01 - Articolo su rivista 2023 Oikonomou A.Saitta C.Valsecchi M. G.Biondi A.Cazzaniga G. +
Hematopoietic Stem Cell (HSC)-Independent Progenitors Are Susceptible to Mll-Af9-Induced Leukemic Transformation 01 - Articolo su rivista 2023 Barone, COrsenigo, RCazzola, APatelli, AQuattrini, GVergani, BBombelli, SDe Marco, SD'Orlando, CBianchi, CLeone, BMeneveri, RBiondi, ACazzaniga, GBrunelli, SAzzoni, E +
High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia 01 - Articolo su rivista 2023 Oikonomou, AValsecchi, LQuadri, MProcopio, SSavino, A. MValsecchi, M. GBiondi, ACazzaniga, GPalmi, C +
miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease 01 - Articolo su rivista 2023 Nucera S.Fazio G.Pagani R.Rambaldi A.Valsecchi M. G.Biondi A.Cazzaniga G. +
Molecular characterisation and clinical outcome of B-cell precursor acute lymphoblastic leukaemia with IG-MYC rearrangement 01 - Articolo su rivista 2023 Cazzaniga, Giovanni +
The recombinome of IKZF1 deletions in B-cell precursor ALL 01 - Articolo su rivista 2023 Palmi C.Fazio G.Saitta C.Cazzaniga G. +
Abnormal B-Cell Maturation and Increased Transitional B Cells in CBL Syndrome 01 - Articolo su rivista 2022 Saettini, FrancescoColiva, Tiziana AngelaGalbiati, MartaCazzaniga, GiovanniBiondi, Andrea +
Clonal dynamics in pediatric B-cell precursor acute lymphoblastic leukemia with very early relapse 01 - Articolo su rivista 2022 Cazzaniga G. +
Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia 01 - Articolo su rivista 2022 Cazzaniga G. +
Conjoined Genes as Common Events in Childhood Acute Lymphoblastic Leukemia 01 - Articolo su rivista 2022 D'Angiò, MariellaCazzaniga, GiovanniFazio, Grazia +